Editor's note: This is a special bonus column for readers of

RealMoney

and

TheStreet.com

. This piece originally was sent to Action Alerts PLUS subscribers. Sign up for Action Alerts PLUS now to find out more about the strategy behind Cramer's trades and get an email alert

before

he makes a trade. For a limited time only, you'll also receive 25% off the usual subscription price and a signed copy of his latest book,

Jim Cramer's Real Money: Sane Investing in an Insane World.

Just click here to get started.

Lucent

(LU)

answered my questions about the warrants and then some, at least, according to the 10-Q that came out last week.

I've been pushing Lucent to use some of its bountiful cash to benefit shareholders. The capitalization is too darned big; there's too much stock. I thought the company should buy in the disastrous warrants, the ones issued last December for the sins of the fathers.

Instead, the company shrewdly bought back $201 million of the convertible securities that have been such a drag on the company since they were issued at the bottom in 2001. This 8% convertible preferred is a legacy piece of business that costs the company a huge amount of money and does nothing to help the current situation.

Image placeholder title

I argued my case to buy in the warrants as forcefully as I could, stressing the psychological impact of buying in something that could be a huge overhang if everything goes well.

However, the use of the $200 million in cash to close out a big chunk of a preferred that required money out the door makes more sense, if you are trying to create long-term enterprise value.

TheStreet Recommends

More important, Lucent chose

not

to use common stock to pay off this paper. It used cash. That shows several things:

    that the solvency of this company is no longer in question; that the business itself is a good one that throws off enough cash that Lucent can afford to spend it on its own securities; and that the financial team is pretty darned savvy in its use of its hoard.

I know that Lucent's been a huge drag of a stock. All I can say after reading through the 10-Q that just came out, is bravo. Management is doing everything right in a horrid industry. When things turn, and they always turn, this will be the horse to be on. I just wish I could double down right here, at $2.63, on the darned thing.

As originally published, this column contained an error. Please see

Corrections and Clarifications.

At the time of publication, Cramer was long Lucent.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column to

jjcletters@thestreet.com. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict."